Disruption of vascular Ca2+-activated chloride currents lowers blood pressure

Journal of Clinical Investigation

Volumn 124, Issue 2, 2014, Pages 675-686

  Heinze, Christoph ^a   Seniuk, Anika ^b   Sokolov, Maxim V ^c   Huebner, Antje K ^a   Klementowicz, Agnieszka E ^c   Szijártó, István A ^d   Schleifenbaum, Johanna ^d   Vitzthum, Helga ^b   Gollasch, Maik ^d   Ehmke, Heimo ^b   Schroeder, Björn C ^c   Hübner, Christian A ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ARTERIOLES; BLOOD PRESSURE; BRAIN; CHLORIDE CHANNELS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ELECTROPHYSIOLOGY; ESTROGEN ANTAGONISTS; HEK293 CELLS; HUMANS; HYPERTENSION; MEMBRANE POTENTIALS; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NEOPLASM PROTEINS; PERICYTES; RETINA; TAMOXIFEN; TIME FACTORS; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 84893862401     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI70025     Document Type: Article

References (54)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-223.
2. Cowley AW Jr. A tribute to Eric Muirhead. Evolution of the Medullipin concept of blood pressure control. Nephrol Dial Transplant. 1995;10(7):1137- 1141.
3. Orlov SN, Tremblay J, Hamet P. NKCC1 and hypertension: a novel therapeutic target involved in the regulation of vascular tone and renal function. Curr Opin Nephrol Hypertens. 2010;19(2):163-168.
4. Matchkov VV, Aalkjaer C, Nilsson H. Distribution of cGMP-dependent and cGMP-independent Ca2+-activated Cl-conductances in smooth muscle cells from different vascular beds and colon. Pflugers Arch. 2005;451(2):371-379.
5. Rust MB, et al. Neurogenic mechanisms contribute to hypertension in mice with disruption of the K-Cl cotransporter KCC3. Circ Res. 2006; 98(4):549-556.
6. Byrne NG, Large WA. Membrane ionic mechanisms activated by noradrenaline in cells isolated from the rabbit portal vein. J Physiol. 1988;404:557-573.
7. Large WA, Wang Q. Characteristics and physiological role of the Ca2+-activated Cl-conductance in smooth muscle. Am J Physiol. 1996;271(2 pt 1):C435-C454.
8. Leblanc N, et al. Regulation of calcium-activated chloride channels in smooth muscle cells: a complex picture is emerging. Can J Physiol Pharmacol. 2005;83(7):541-556.
9. Caputo A, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 2008;322(5901):590-594.
10. Schroeder BC, Cheng T, Jan YN, Jan LY. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell. 2008;134(6):1019-1029.
11. Yang YD, et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature. 2008;455(7217):1210-1215.
12. Charlesworth G, et al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet. 2012; 91(6):1041-1050.
13. Bolduc V, et al. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet. 2010;86(2):213-221.
14. Suzuki J, Umeda M, Sims PJ, Nagata S. Calciumdependent phospholipid scrambling by TMEM16F. Nature. 2010;468(7325):834-838.
15. Vermeer S, et al. Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia. Am J Hum Genet. 2010;87(6):813-819.
16. Malvezzi M, et al. Ca2+-dependent phospholipid scrambling by a reconstituted TMEM16 ion channel. Nat Commun. 2013;4:2367.
17. Davis AJ, et al. Expression profile and protein translation of TMEM16A in murine smooth muscle. Am J Physiol Cell Physiol. 2010;299(5):C948-C959.
18. Manoury B, Tamuleviciute A, Tammaro P. TMEM16A/ anoctamin 1 protein mediates calcium-activated chloride currents in pulmonary arterial smooth muscle cells. J Physiol. 2010;588(pt 13):2305-2314.
19. Bulley S, et al. TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries. Circ Res. 2012;111(8):1027-1036.
20. Thomas-Gatewood C, et al. TMEM16A channels generate Ca2+-activated Cl-currents in cerebral artery smooth muscle cells. Am J Physiol Heart Circ Physiol. 2011;301(5):H1819-H1827.
21. Wang M, et al. Downregulation of TMEM16A calcium-activated chloride channel contributes to cerebrovascular remodeling during hypertension by promoting basilar smooth muscle cell proliferation. Circulation. 2012;125(5):697-707.
22. Rock JR, Futtner CR, Harfe BD. The transmembrane protein TMEM16A is required for normal development of the murine trachea. Dev Biol. 2008;321(1):141-149.
23. Schwenk F, Baron U, Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxPflanked gene segments including deletion in germ cells. Nucleic Acids Res. 1995;23(24):5080-5081.
24. Wirth A, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med. 2008; 14(1):64-68.
25. Kiermayer C, Conrad M, Schneider M, Schmidt J, Brielmeier M. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate. Genesis. 2007;45(1):11-16.
26. Levick RJ. An Introduction Into Cardiovascular Physiology. 5th ed. Boca Raton, Florida, USA: CRC Press; 2011.
27. Sims DE. The pericyte - a review. Tissue Cell. 1986; 18(2):153-174.
28. Dalkara T, Gursoy-Ozdemir Y, Yemisci M. Brain microvascular pericytes in health and disease. Acta Neuropathol. 2011;122(1):1-9.
29. Sakagami K, Wu DM, Puro DG. Physiology of rat retinal pericytes: modulation of ion channel activity by serum-derived molecules. J Physiol. 1999;521(part 3):637-650.
30. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193-215.
31. Zhang Q, Cao C, Zhang Z, Wier WG, Edwards A, Pallone TL. Membrane current oscillations in descending vasa recta pericytes. Am J Physiol Renal Physiol. 2008;294(3):F656-F666.
32. Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res. 2006;98(3):322-334.
33. Belz GG. Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther. 1995;9(1):73-83.
34. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation. 2001;104(6):735-740.
35. Mendelsohn ME. In hypertension, the kidney is not always the heart of the matter. J Clin Invest. 2005;115(4):840-844.
36. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens. 2011;24(8):843-853.
37. McCurley A, et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med. 2012;18(9):1429-1433.
38. Albinsson S, et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One. 2011;6(4):e18869.
39. Su W, Xie Z, Liu S, Calderon LE, Guo Z, Gong MC. Smooth muscle-selective CPI-17 expression increases vascular smooth muscle contraction and blood pressure. Am J Physiol Heart Circ Physiol. 2013;305(1):H104-H113.
40. Pallone TL, Zhang Z, Rhinehart K. Physiology of the renal medullary microcirculation. Am J Physiol Renal Physiol. 2003;284(2):F253-F266.
41. Pallone TL, Huang JM. Control of descending vasa recta pericyte membrane potential by angiotensin II. Am J Physiol Renal Physiol. 2002;282(6):F1064- F1074.
42. Zhang Z, Huang JM, Turner MR, Rhinehart KL, Pallone TL. Role of chloride in constriction of descending vasa recta by angiotensin II. Am J Physiol Regul Integr Comp Physiol. 2001;280(6):R1878-R1886.
43. Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275(20):1581-1589.
44. Kurtz A, Penner R. Angiotensin II induces oscillations of intracellular calcium and blocks anomalous inward rectifying potassium current in mouse renal juxtaglomerular cells. Proc Natl Acad Sci U S A. 1989;86(9):3423-3427.
45. Kurtz A. Renin release: sites, mechanisms, and control. Annu Rev Physiol. 2011;73:377-399.
46. Nabel C, Schweda F, Riegger GA, Kramer BK, Kurtz A. Chloride channel blockers attenuate the inhibition of renin secretion by angiotensin II. Pflugers Arch. 1999;438(5):694-699.
47. Bandopadhyay R, Orte C, Lawrenson JG, Reid AR, De Silva S, Allt G. Contractile proteins in pericytes at the blood-brain and blood-retinal barriers. J Neurocytol. 2001;30(1):35-44.
48. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009;15(9):1031-1037.
49. Rust MB, et al. Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice. J Clin Invest. 2007;117(6):1708-1717.
50. Dietrich A, et al. Increased vascular smooth muscle contractility in TRPC6-/-mice. Mol Cell Biol. 2005;25(16):6980-6989.
51. Puro DG. Retinovascular physiology and pathophysiology: new experimental approach/new insights. Prog Retin Eye Res. 2012;31(3):258-270.
52. Fésüs G, et al. Adiponectin is a novel humoral vasodilator. Cardiovasc Res. 2007;75(4):719-727.
53. Mathar I, et al. Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest. 2010;120(9):3267-3279.
54. Moosmang S, et al. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J. 2003;22(22):6027-6034.